The main protease (Mpro) of the SARS-CoV-2 virus is one focus of
drug development efforts for COVID-19. Here, we show that
interactive molecular dynamics in virtual reality (iMD-VR) is a
useful and effective tool for creating Mpro complexes. We make
these tools and models freely available. iMD-VR provides an
immersive environment in which users can interact with MD
simulations and so build protein complexes in a physically
rigorous and flexible way. Recently, we have demonstrated that
iMD-VR is an effective method for interactive, flexible docking
of small molecule drugs into their protein targets (
32160194
PLoS
One
2020
15
e0228461
). Here, we apply
this approach to both an Mpro inhibitor and an oligopeptide
substrate, using experimentally determined crystal structures.
For the oligopeptide, we test against a crystallographic
structure of the original SARS Mpro. Docking with iMD-VR gives
models in agreement with experimentally observed (crystal)
structures. The docked structures are also tested in MD
simulations and found to be stable. Different protocols for
iMD-VR docking are explored, e.g., with and without restraints
on protein backbone, and we provide recommendations for its use.
We find that it is important for the user to focus on forming
binding interactions, such as hydrogen bonds, and not to rely on
using simple metrics (such as RMSD), in order to create
realistic, stable complexes. We also test the use of apo
(uncomplexed) crystal structures for docking and find that they
can give good results. This is because of the flexibility and
dynamic response allowed by the physically rigorous, atomically
detailed simulation approach of iMD-VR. We make our models (and
interactive simulations) freely available. The software
framework that we use, Narupa, is open source, and uses
commodity VR hardware, so these tools are readily accessible to
the wider research community working on Mpro (and other COVID-19
targets). These should be widely useful in drug development, in
education applications, e.g., on viral enzyme structure and
function, and in scientific communication more generally.